April 14, 2012

Early Basal Insulin Therapy Decreases New-Onset Diabetes after Renal Transplantation


Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177
.   .   

Diabetes is a common complication post-renal transplant that affects long-term patient and graft survival. In this small randomized-controlled trial, patients were Randomized to treatment with basal insulin for fasting glucose > 7.8 mold/L, or standard care. Patients in the treatment arm were less likely to develop diabetes during the first year post-transplant, and had a lower HbA1c.

Renal Transplantation

Tags: , , , , ,